Bloodstream Infection
52
8
10
21
Key Insights
Highlights
Success Rate
84% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
4 terminated out of 52 trials
84.0%
-2.5% vs benchmark
10%
5 trials in Phase 3/4
29%
6 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (52)
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Next Generation Pathogen Sequencing for Prediction of Adverse Events
Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients
Advanced Dressings for CVC Infection Prevention in PICU
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST)
Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections
Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort Study
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia
European Prospective Bloodstream Infection Cohort
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
Optimising TREATment for Severe Gram-Negative Bacterial Infections
The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia
Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit
Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
Pragmatic Randomized Trial for Arterial Catheters in the Critical Care Environment
ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs